Phase 1/2Completed
Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty
Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology (Academic or other)
- Enrolment
- 158 enrolled
- Conditions
- Frailty
- Interventions
- Umbilical Cord Mesenchymal Stem Cells transplantation; standard frailty treatment and supplementary medication
- Ages
- adults, older adults
- Registry
- NCT04919135
From the registry
This trial is to investigate the safety and potential therapeutic efficacy of allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard frailty treatment in Vietnam
Primary outcomes
- Adverse events and serious adverse events